|
Título:
|
Treatment for hemophilia: recombinant versus plasma-derived coagulationfactors – controversy and debateforever? An ethical medical challenge?
|
|
Autores:
|
Liras, Antonio ;
García-Tenchard, Rebecca
|
|
Tipo de documento:
|
texto impreso
|
|
Editorial:
|
Informa Healthcare, 2013-10
|
|
Dimensiones:
|
application/pdf
|
|
Nota general:
|
info:eu-repo/semantics/restrictedAccess
|
|
Idiomas:
|
|
|
Palabras clave:
|
Estado = Publicado
,
Materia = Ciencias Biomédicas: Medicina: Farmacología
,
Materia = Ciencias Biomédicas: Medicina: Hematología
,
Tipo = Artículo
|
|
Resumen:
|
With the eradication of infection by HIV and hepatitis C virus that were common just a few years ago, the most concerning adverse effect resulting from the use of both recombinant and plasma-derived products is the appearance of antibodies (inhibitors) to perfused exogenous factors.”
|
|
En línea:
|
https://eprints.ucm.es/id/eprint/30713/1/Liras%20ERH%202013.pdf
|
